An ultra-stable cytoplasmic antibody engineered for in vivo applications
Antibodies expressed in the cytosol often form insoluble aggregates, which makes it hard to target intracellular proteins. Here the authors engineer an ultra-stable cytoplasmic antibody (STAND) with a low isoelectric point that can be used in vivo.
Saved in:
Main Authors: | Hiroyuki Kabayama, Makoto Takeuchi, Naoko Tokushige, Shin-ichi Muramatsu, Miyuki Kabayama, Mitsunori Fukuda, Yoshiyuki Yamada, Katsuhiko Mikoshiba |
---|---|
Format: | article |
Language: | EN |
Published: |
Nature Portfolio
2020
|
Subjects: | |
Online Access: | https://doaj.org/article/f9143607edfe4e95b8e2df11ca430e7f |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Optically driven ultra-stable nanomechanical rotor
by: Stefan Kuhn, et al.
Published: (2017) -
Antineutrophil cytoplasmic antibodies-associated glomerulonephritis: From bench to bedside
by: Yong-Xi Chen, et al.
Published: (2018) -
Downregulation of cytoplasmic DNases is implicated in cytoplasmic DNA accumulation and SASP in senescent cells
by: Akiko Takahashi, et al.
Published: (2018) -
Engineered adeno-associated virus 3 vector with reduced reactivity to serum antibodies
by: Mika Ito, et al.
Published: (2021) -
Specific in vivo labeling of tyrosinated α-tubulin and measurement of microtubule dynamics using a GFP tagged, cytoplasmically expressed recombinant antibody.
by: Lynne Cassimeris, et al.
Published: (2013)